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A (t)
= exp{-fJa.(xIz)dxc
= exp - az(i) -fa0(xlz)dx}
(4)
To assess risk of environmental agents by
animal carcinogenicity experiments in the
past, statisticians would carry out trend tests
to determine ifthe agents were carcinogenic.
One well-known carcinogenicity test is the
Armitage-Cochran test (1,2). Portier and
Bailer (3) pointed out that such tests are sub-
jected to serious biases when agents are toxic
or when there are causes ofdeath other than
cancer. To correct for such biases, Portier
and Bailer (3) have proposed a 3-poly test
based on the classical Armitage-Doll model
ofcarcinogenesis. Because theArmitage-Doll
cancer model does not take proliferation of
intermediate cells into account [see Tan (4)],
one maywonder ifthe method is robust and
efficient under other realistic models of car-
cinogenesis. To answer these questions, we
generated Monte Carlo studies ofthis test by
using a two-stage model ofcarcinogenesis as
described by Moolgavkar and Knudson (5).
The basic reason we used this model is that it
has strong biological support [see Tan (4)].
Because the two-stage model and its exten-
sions are complex enough to involve stochas-
tic proliferation and differentiation ofinitiat-
ed cells and yet simple enough to be applica-
ble to many data sets, this model has been
suggested as the basic model for assessing risk
ofenvironmental agents (6).
We will briefly describe the model and
how Monte Carlo data can be generated;
we will then apply the 3-poly methods to
the data. To assess the efficiency and
robustness of the test, we will compute the
Monte Carlo size and the power ofthe test.
Finally, we will discuss the results and some
ofthe issues relevant to the method.
The Model and Generation of
Monte Carlo Data
To generate Monte Carlo studies, animal
carcinogenicity experiments were carried out
in which healthy animals were exposed to
different dose levels of the carcinogen at
to-0 and are followed up until time tM= tk.
In the group ofanimals exposed to the car-
cinogen with dose level z, let a,(jlz) and
a2(jIlz) denote the numbers of animals
which died at timejwithout and with can-
cerous tumors, respectively; similarly, in the
group ofanimals exposed to the carcinogen
with dose level z, let b1(z) and b2(z) be the
numbers ofterminal sacrifices without and
with cancerous tumors, respectively.
To generate Monte Carlo data from
such an experiment, we assign Das the ran-
dom variable for the time to death, Tas the
random variable for the time to the onset of
cancer tumors, and Zas the variable for the
dose level. Given Z=z, let o0(tjz), O(tls,z),
(t > s), and ko(tlz) be the incidence func-
tions of death without cancer, death with
cancer being developed at s, and cancerous
tumors, respectively. Then,
a (tlz) = limA P{DE
[t,t+At)ID.t,T 2t,Z=z},
3o(tls,z)
=limpJt{D r At--~0
[t,t +At)[D t,T = s,Z =z}
and
A(tlz)
=li A r PI T E AtITO
[t,t+At)p)2t, T 2t,Z=z}
(1)
(2)
(3)
Forj < t <j+1, the survival functions asso-
ciated with cx0(tlz), P,0(tls,z), and ko(tlz)
are given respectively by
Bo(tli) =exp{-fP (xk,z)d}
=exp -I1z(uk)-f0(xk,z)d4
(5)
forj>i, and
A (t) = exp -JA0(xlz)dx}
= exp{-XA (i) - (xlz)dx
where a (i) =J1a.(xlz)dx,f3z(jls)
=j0 t(xs x forj-12 s, andAZW
=.f17lo(xIzkPc
Assume that 300(tls,z) = 00(tli,z) for i-l
< s < i and that during one time unit, the
event of death and the event of developing
cancerous tumors are independent of each
other. Then Pz(tIs) = Pz(tIi) for i-I < s < i <
t, and the probabilities for generating
a,(jIz), a2(jlz), b1(z), b2(z) are given
respectively by
PiCIz)=Pr{DE i-1,j),T2jID2j-1, Z=z}
=[AzU- l)-Az(j)] Azy) (7)
P2(jlz)= P{D E[j-1,j),T <jp 2j-1,
z = }=[Az(j-i)- Az(j)]
[Az(j-1)-Az(j)] + A(i)
i=l
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[A (i -1)-A (i)]
[B.(j -1>) -B.(j>)
P1(Miz) = P{D > t;,T > tk,IZ = Z}
3 r k ) ( k 'IZ
= A(ztk)A(ztk)
P4(MIz) =Pr{D>tk,T tkjZ =z}
= IAz(j)Az(j -1)
j=l
-Az(j)}z(tkIj)
TheTwo-stage Model of
Carcinogenesis
Let v,(tlz) and v2(tlz) denote the mutation
(8) rates at time tofthe first event and the sec-
ond event, respectively, for animals exposed
to the carcinogen with dose level z. Let
@(y,ws,t) = 4)(s,t) be the probability gener-
ating function of the number of initiated
(9) cells (I cells) and cancerous tumor cells (T
cells) at time t, given one initiated cel arising
from a normal stem cell at time s. The two-
stage model ofcarcinogenesis specifies that
(10)
Ao(tlz)
= V2(tlz)tN (t,x)v,(XlZ)
{f@ o (y,O;x,dt)d
vI(tjz) = V1(Z), V2(tlZ) = V2(Z), b1(tlZ)
= b1(z), and d1(tlz) = ds(Z)
we have
A (tlz) = N v(z)v2(z)Jf(x)e(z)(t-x)
{1 (zz)( t-X) I dx
N v(z)v2(z)Jfz(t -x)
X{+1 2()(
(11) and
Theorem 1. With P1(JIz), P2(jIz), P3(z),
and P4(z), as given above, one has
P (z) + 4(z) + (ilz) +P2(jl)] = 1
j=1
Proof. Let P3(lIz) and P4(jIz) be obtained
from P3(z) and P4(z), respectively, by
replacing tk= tM bytj. Note that BA(j1j) =1
for]i=2, , tk=tM
±iP(ijz) = P(i -1lz) +P4(1-1lz)
It follows that
where Nz (t) is the number ofnormal stem
cells in the cell division stage at time t.
Note that mutations occur only during cell
division. [For theproofofEquation 11 and
for the general theory of two stage models
ofcarcinogenesis, see Tan (4), chapter 3].
Note that Nz(t) = Nofz(t), where No is
the total number of normal stem cells at
time 0, and where fz(t) is the density of
first passage time to the cell division stage
at time tfor normal stem cells at time 0.
Let b/tlz) and d/tiz) denote the birth
rate and death rate at time tofinitiated cells
for animals exposed to the carcinogen with
dose level z. Suppose that b/tlz) = bXz),
dXtlz) = dXz), v,(tlz) = v,(z), and v2(tlz) =
v2(z) are independent oftime t. Then
P (Mjz)
+ P4 (MIZ) IP (jAz) P2(lz)] { O(Y,O;S,t)}
= I[P (jlz) + P (jlz)] + ±P(MIz) = z()(t-S)1 + (z((z)(tS) (12
Az(j) = ji1A0(tlz)dt =GZ(t)-G (t -1)
where
Gz(j) = f (xiz)dx
= 1(z)W2(z) fJ ( -x)
{1+ 0)e -1}
(14)
and01(z)=NOvI(z)V2(z)/[01(Z)02(Z)]
Iff(t)=1, thenkX(tlz) inEquation 13 and
Gz(j) inEquation 14reducerespectivelyto
AO(tkz)
= 1(z){1 [ + 2(z)(e
- I
[(jlZ) +P(]jlz)] +P3(M -llz'
+P4(M-lilz)
= [P (1lz) + P2(liz)] +P3(ilz) + P4(lIz)
=1
Given ao(tlz), 130(ts,z), and XO(elz), by
Theorem 1 one may readily generate
observed numbers of a1lIz), a2(ilz), bl(z),
and b2(z) by computer. A simple algorithm
for generating these observed numbers is
given in the Appendix.
where
P1(z)
={[b1(z) +d1(Z) +V2(Z)]
-4b(z)d (z)}
and
02(Z)=
{01(z) -[bi(z) + d (z)] +v2(Z)}
It follows that for the homogeneous
model inwhich
and
G(j) = (z)()
z I ~~[e(z)]
1+ 02(z)(e- I
=A(z){-1e-1(z)+
log[l +02(z)(e })j 1)j}
(16)
whereA(z)=Nov1(z)v2(z)/{¢(z) [1-02(z)]}
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The 3-Poly Test
To adjust for toxicity and effects on survival
of the agents, Bailer and Portier (7) and
Portier and Bailer (3) proposed a 3-poly test
to determine ifthe agents are carcinogenic.
The first step ofthis test is to compute the
weight co. for each animal and adjust the
estimates of quantal response by using this
weight. A modified X2-test is then derived
by substituting the adjusted estimates of
quantal response into the Cochran-
Armitage trend test. Specifically, the proce-
dure is given in the following steps.
If co,. is the weight for thej animal in
the group of animals exposed to the car-
cinogen with dose level di and t.-is the
time ofdeath including sacrifice ofthis ani-
mal, then based on theArmitage-Doll mul-
tistage model, Bailer and Portier (7)
derived co as CO =(t1tM)k where tMis the
termination time of the experiment. For
practical purposes, k was taken as 3, thus
giving the terminology ofthe 3-poly test.
IfS..is the indicator function defined by
6i.=1 if'the animal died (including sacrifice)
with tumors at tijand 8,., =0 if the animal
died without tumors at t4,, and ni is the
number ofanimals in the group exposed to
the carcinogen with dose z,, then the adjust-
ed estimate of the quantal response to the
dose level ziis x(?)/m°), where
i j=i co and m () Xi() =Ejn' 1bij)ijnd i° = E*1°ij
On substituting the adjusted estimates
of the quantal response into the Cochran-
Armitage trend test, Portier and Bailer (3)
derived the following X statistic:
=[ M(O) 1 ;(M(°)-X(J) X(°)
{Xlo(x(o) -r(O)X(0))z}
{XI(0)2 {Xr(o)z}2 E=io i Zi {i=o i Zi}}
whereM°O)==:in0,X(°) =X 1x0,r(°)
=Mi(°)/M(), and zi, i=0, 1, 4 I, are the
dose levels.
Thus, one rejects the null hypothesis at
level a to conclude that the agent is car-
cinogenic if X2 > X(1,a) where X(1,a) is
the upper a% of the X2 distribution with
one degree offreedom. The p-value of the
test is the probability that %2 > X2 where
x denotes a X2 distribution with one
degree offreedom.
Portier and Bailer (3) obtained the p-
values for the Cochran-Armitage trend test
and for the modified Cochran-Armitage
test as 0.528 and 0.034, respectively. Thus,
the Cochran-Armitage trend test failed to
detect the carcinogenicity ofthe agent, but
the modified test indicated that the chemi-
cal is carcinogenic at the significant level
0.05. This result suggests the usefulness of
the modified test.
Generation of Monte Carlo
Studies
In this section we will assume some para-
meter values and use the model to generate
Monte Carlo data to assess the efficiency
and robustness ofthe 3-poly test. To illus-
trate the results, we will assume four dose
levels z=0, 25, 50, and 100.
Selection ofParameterValues
To make the model more realistic, we will
select the parameter values from estimates
in published papers and discuss these para-
meters below.
Survivalparameters. Because Portier et
al. (8) have shown that the survival func-
tions of Fischer rats are best fitted by the
modified Weibull model, we chose the
incidence ofdeath without tumors by
az(t) = I+a,z)(a1 + t
a =1.2372 104
a =2.4785*106 2
a = 7.3839
a0 =0,1,2,4 (18)
Note that the above values ofaiwere
estimates by Portier et al. (8) on Fischer
rats. If a0=0, then az(t)=a(t) is indepen-
dent of z so that the carcinogen has no
toxic effects on the survival of animals.
Thus ao provides a measure for the toxicity
ofthe carcinogen.
Following Bailer and Portier (7), we
assume that the incidence Pz(tIs) of death
with cancer tumors being developed during
[s-1,s) is
Z3(tks) =(1+OZ)[I(t
-s)+
+ 2{ (st3) +00I2(t S)3tM
(19)
where Oo=2 and 6=1,2.
Theparametersofgrowth oftumorcells.
Following Tan and Chen (9), we assume
that for each tumor cell arising at time s, the
probability that this tumor cell will divide
for the first time during [t,t+ At) is YT(sIt)
At + O(At). Given that a tumor cell divides
during [t,t+ 1), we assume that at the end
ofcell turnover this tumor cell either gives
rise to two tumor cells with probability
aT(t) or dies with probability PT(t). For
the Monte Carlo studies, we assume that
YT(slt)=YT, aT(t)=aT, and P T(t)= T
Then, as shown in Tan and Chen (9), the
probability that a tumor cell at time t will
eventually develop into a cancerous tumor
is given by q=1-(BT/aT). For the genera-
tion ofdata, we take q = 0.80.
Cancerparameters. Because mutations
take place only during cell division, we will
follow Chen and Farland (10) to assume
that for mutations, cell proliferation, and dif-
ferentiation to take place, cells must first
enter into the division stage from the resting
stage. LetfN(to,t)be the probability density
of the first passage oftime from the resting
stage at to to the cell division stage at time t
for normal stem cells. Let v,(z) be the muta-
tion rate at time tofnormal stem cells. Then,
to order o(At), v1(z)(At) is the probability of
giving rise to one normal stem cell and one
initiated cell, given cell division ofa normal
stem cell during [t,t+ At). Furthermore, to
order o(At), NofN(to,t) vj(z)(At) is the
average number ofnew initiated cells arising
from normal stem cells during [t,t+ At) given
Nonormal stem cells at time to. For generat-
ing Monte Carlo data, we take No = 107and
assumefN(to,t) as a gamma density with the
mode at time 13 and with a scale parameter
aas 16.5.
To model the proliferation and muta-
tion of I cells, we followed Chen and
Farland (10) to assume that for animals
exposed to the carcinogen with dose level z,
the probability that each I cell will divide
during [t,t+ At) is y1(z)At +o(At) =
(yO+y1z)At+o(At). Given that an I cell
divides during [t,t+ At), we assume that at
the end of cell turnover, this I cell will
either give rise to two I cells with probabili-
ty a1, one I cell and one tumor cell with
probability PI, or die with probability V,
(ai + I + VI
= 1). Then, as shown in Tan
and Chen (9),
= ( () r O)° (20)
and
(21)
where
o=[(a, +p3 +qv) _4ai1 ]2
(22)
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and
q = 1- jT
(23)
For the generation of Monte Carlo
data, we take yo=1-e015 _71=0, 0.5, 1, 2,
ai=0.52, 0I3=0.479999, and V1=10-7 with
q=0.8. Note that if yr=O then y1(z)=y0 is
independent ofzso that the carcinogen has
no effects on the proliferation of I cells. It
follows that y1 provides a measure for the
increased proliferation of I cells due to the
action of the carcinogen. We will thus use
7y as a measure for thepromoting effects of
the carcinogen.
Finally, for the mutation rates, we take
v2(z)=10-7. Also, we follow Moolgavkar et
al. (11) to assumeVj(z)=p__eO12log91+z). For
generation of data, we take p10=10-7,
012=0, 0.1, and 0.92. Note that if 012=0,
then v1(z)=p10 is independent of z. It fol-
lows that 012 provides a measure for the
increased mutation rate over the sponta-
neous rate due to the action ofthe carcino-
gen. Thus we will use 012 as a measure for
the initiating effects ofthe carcinogen.
With the parameter value given above,
we have used the Monte Carlo model to
generate independent random samples. For
each random sample, we assume four dose
levels 0, 25, 50, and 100; the sample size is
assumed to be 50 to comply with the sam-
ple size given by the example in Bailer and
Portier (7). Five hundred independent
random samples were generated under each
condition. The Monte Carlo p-values for
the case in whichfzt is a gamma density
are shown in Table 1. The corresponding
Monte Carlo p-values in the case f (t)=1
are shown in Table 2.
The following observations are made
from the results ofTables 1 and 2:
-Ify1>0 and 012 >0 so that the carcino-
gen is a complete carcinogen (i.e., both an
initiator and promoter), then the 3-poly
test appears to be quite powerful in detect-
ing the carcinogenic effects ofthe agent in
question.
*lfyl>0 is moderate or large so that the
carcinogen is a promoter with moderate or
large effect, the 3-poly test is quite power-
ful in detecting the carcinogenic effects of
the agent in question, even though the
effect of an initiator is very small. On the
other hand, if 012=0 and 'y>° is small so
that the carcinogen is a weak promoter
without the presence of an initiator, then
the 3-poly test may not be a powerful test
for detecting the carcinogenic effect of the
agent unless the toxicity ofthe agent is not
strong or the proliferation rate of the nor-
mal stem cells is zero (i.e., f (t)=1). In any
Table 1. The Monte Carlo p-values of the 3-poly
testwhen f (t) is gamma
Initiator Promotor Promotor Monte Carlo
012 VI CO p-value
0.00 0.00 0.00 0.0540
0.00 0.00 1.00 0.0740
0.00 0.00 4.00 0.00001
0.00 0.50 0.00 0.3080
0.00 0.50 1.00 0.9380
0.00 0.50 4.00 0.0180
0.00 1.00 0.00 0.8300
0.00 1.00 1.00 1.0000
0.00 1.00 4.00 1.0000
0.10 0.00 0.00 0.1060
0.10 0.00 1.00 0.4900
0.10 0.00 4.00 0.3940
0.10 0.50 0.00 0.7640
0.10 0.50 1.00 1.0000
0.10 0.50 4.00 1.0000
0.10 1.00 0.00 0.9520
0.10 1.00 1.00 1.0000
0.10 1.00 4.00 1.0000
0.92 0.00 0.00 0.9740
0.92 0.00 1.00 1.0000
0.92 0.00 4.00 1.0000
0.92 0.50 0.00 0.9880
0.92 0.50 1.00 1.0000
0.92 0.50 4.00 1.0000
case, however, the 3-poly test is at least as
good as the Armitage-Cochran test. This is
expected since the Armitage-Cochran test
may not detect the carcinogenic effects of
the chemical, even in situations in which
the carcinogen is a promoter with moder-
ate effect, due to the toxicityofthe agent.
*If 012>0 is moderate or large so that
the carcinogen is an initiator with moderate
or large effect, the 3-poly test is quite pow-
erful in detecting the carcinogenic effects of
the agent in question, regardless ofwhether
a promoter is present or not. On the other
hand, ify1=0 and 012>0 is small so that the
carcinogen is a weak initiator without the
presence ofpromoting agents, then in some
cases, the p-values can be very small,
depending on the toxicity of the agent. In
these cases, the 3-poly test may not be a
powerful test for detecting the carcinogenic
effects of the agent. In any case, however,
the 3-poly test is at least as powerful as the
Armitage-Cocharan test, which is expected
because theArmitage-Cochran test may not
detect the carcinogenic effects ofthe agent,
even in situations in which the carcinogen
is an initiator with moderate effect, due to
the toxicity ofthe agent.
*From Tables 1 and 2, we observe that
when Ho is true (i.e., the agent is not car-
cinogenic), the probability (thep-values) of
rejecting Horanges from 0.0001->0.09.
Furthermore, this probability is <0.05 only
when there is high toxicity (in this case,
there were probably few tumor responses).
These results suggest that at the 0.05 level,
Table 2. The Monte Carlo p-values of the 3-poly
testwhen fz(t)=1
Initiator
012
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.10
0.92
0.92
0.92
0.92
0.92
0.92
0.92
0.92
0.92
Promotor
vi
0.00
0.00
0.00
0.50
0.50
0.50
1.00
1.00
1.00
0.00
0.00
0.00
0.50
0.50
0.50
1.00
1.00
1.00
0.00
0.00
0.00
0.50
0.50
0.50
1.00
1.00
1.00
Promotor
aO
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
0.00
1.00
4.00
Monte Carlo
p-value
0.0620
0.0960
0.0200
0.2700
0.8920
0.8260
0.2040
1.0000
1.0000
0.0720
0.2460
0.0620
0.4660
0.9980
0.9960
0.9320
1.0000
1.0000
0.9980
1.0000
1.0000
0.9940
1.0000
1.0000
1.0000
1.0000
1.0000
Homay be rejected even though Hois true.
Note that Hois true if, and only if, yI=°
and 012=0. Thus, ifHois true, the prolifer-
ation rate ofthe I cells is the same over dif-
ferent dose levels, and the mutation rate
from normal stem cells to I cells equals the
spontaneous rate of this mutation, regard-
less ofwhether the carcinogen is present.
*Results in Tables 1 and 2 indicate that
the decision reached by the 3-poly test is
quite robust with respect to the toxicity of
the carcinogen. This suggests that the 3-poly
test has achieved its intended purpose for
adjustingfor the toxicityeffects ofthe agent.
Conclusions and Discussion
To adjust for the toxic effects or competing
death from the carcinogen, Bailer and
Portier (1O) and Portier and Bailer (3) have
proposed a 3-poly test to determine the car-
cinogenic effects of the agent. Because this
test is based on the dassical Armitage-Doll
model ofcarcinogenesis and because the lat-
ter model does not take into account the
cell proliferation of the normal stem cells
and the intermediate cells (initiated cells)
and is not supported by modern cancer
biology [see Tan (4)], one maywonderhow
the 3-poly test would perform under some
real situations. To answer these questions,
we have generated Monte Carlo studies by
using the two-stage model of carcinogene-
sis. The main reason that we chose the two
stage model is that it has strong biological
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support and is simple enough to be applica-
ble to manydatasets (4,6).
Our results have indicated that, as it was
intended, the 3-polytest isveryinsensitive to
the toxic effects and competing death ofthe
carcinogen. In all cases, when the agent is
not carcinogenic, thep-values are, in general,
quite small so that the type-I error ofthe test
is quite small. Thus, the testwould not reject
the null hypothesis that the agent is not car-
cinogenic whenever the agent is truly not
carcinogenic. Ifthe agent is a complete car-
cinogen, a moderate promoter, or an initia-
tor with moderate effect, the 3-poly test is
usuallyvery powerful for testing the carcino-
genic effects of the agent. However, if the
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agent is a weak initiator and there are no
promoters present, then the power ofthe test
could be verysmall in some cases, depending
on the toxicity ofthe agent. Similarly, ifthe
agent is a weak promoter and there are no
initiators present, then depending on the
toxicity ofthe agent, the 3-poly test may not
be a powerful test for detecting the carcino-
genic effects of the agent, in some cases. In
anycase, the 3-polytest is at least as powerful
as theArmitage-Cochran test.
From this analysis, one may conclude
that the 3-poly test, as proposed by Portier
and Bailer (3) is quite robust and powerful
for detecting carcinogenic effects ofcomplete
carcinogens, moderate promoters, and initia-
tors with moderate or large effect. It is less
powerful for detecting carcinogenic effects of
the agent if the agent is a weak initiator in
the absence ofpromoters or aweakpromoter
in the absence of initiators (in some cases).
Because the mutation rate of the second
mutational event is very small (e.g., 10-7/cell
in the generated data), these results may be a
consequence ofthe fact that a weak initiator
can only give rise to a very small number of
initiated cells, which can hardly be sustained
in the population in the absence ofpromot-
ers. Similarly, ifthe promotional effect ofthe
promoter is veryweak, the second mutation-
al event can hardly take place among the
small number of initiated cells that arise
from spontaneous mutation ofthe first event
in the absence ofinitiators.
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